Annual Working Capital
$540.83 M
+$204.74 M+60.92%
31 December 2023
Summary:
Akero Therapeutics annual working capital is currently $540.83 million, with the most recent change of +$204.74 million (+60.92%) on 31 December 2023. During the last 3 years, it has risen by +$282.60 million (+109.44%). AKRO annual working capital is now at all-time high.AKRO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$703.60 M
-$41.24 M-5.54%
30 September 2024
Summary:
Akero Therapeutics quarterly working capital is currently $703.60 million, with the most recent change of -$41.24 million (-5.54%) on 30 September 2024. Over the past year, it has increased by +$156.06 million (+28.50%). AKRO quarterly working capital is now -20.14% below its all-time high of $881.02 million, reached on 31 March 2024.AKRO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +60.9% | +28.5% |
| 3 y3 years | +109.4% | +254.9% |
| 5 y5 years | +623.1% | +390.8% |
AKRO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +221.1% | -20.1% | +382.4% |
| 5 y | 5 years | at high | +623.1% | -20.1% | +584.4% |
| alltime | all time | at high | >+9999.0% | -20.1% | +930.2% |
Akero Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $703.60 M(-5.5%) |
| June 2024 | - | $744.84 M(-15.5%) |
| Mar 2024 | - | $881.02 M(+62.9%) |
| Dec 2023 | $540.83 M(+60.9%) | $540.83 M(-1.2%) |
| Sept 2023 | - | $547.53 M(-11.9%) |
| June 2023 | - | $621.60 M(+87.9%) |
| Mar 2023 | - | $330.81 M(-1.6%) |
| Dec 2022 | $336.09 M(+99.5%) | $336.09 M(-4.7%) |
| Sept 2022 | - | $352.70 M(+124.0%) |
| June 2022 | - | $157.45 M(+8.0%) |
| Mar 2022 | - | $145.84 M(-13.4%) |
| Dec 2021 | $168.45 M | $168.45 M(-15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $198.27 M(-9.8%) |
| June 2021 | - | $219.76 M(-10.5%) |
| Mar 2021 | - | $245.64 M(-4.9%) |
| Dec 2020 | $258.23 M(+100.7%) | $258.23 M(-9.7%) |
| Sept 2020 | - | $286.02 M(+178.2%) |
| June 2020 | - | $102.80 M(-12.8%) |
| Mar 2020 | - | $117.93 M(-8.4%) |
| Dec 2019 | $128.68 M(+72.1%) | $128.68 M(-10.2%) |
| Sept 2019 | - | $143.35 M(-9.5%) |
| June 2019 | - | $158.37 M(+131.9%) |
| Mar 2019 | - | $68.30 M(-8.7%) |
| Dec 2018 | $74.79 M(>+9900.0%) | $74.79 M |
| Dec 2017 | $416.00 K | - |
FAQ
- What is Akero Therapeutics annual working capital?
- What is the all time high annual working capital for Akero Therapeutics?
- What is Akero Therapeutics annual working capital year-on-year change?
- What is Akero Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Akero Therapeutics?
- What is Akero Therapeutics quarterly working capital year-on-year change?
What is Akero Therapeutics annual working capital?
The current annual working capital of AKRO is $540.83 M
What is the all time high annual working capital for Akero Therapeutics?
Akero Therapeutics all-time high annual working capital is $540.83 M
What is Akero Therapeutics annual working capital year-on-year change?
Over the past year, AKRO annual working capital has changed by +$204.74 M (+60.92%)
What is Akero Therapeutics quarterly working capital?
The current quarterly working capital of AKRO is $703.60 M
What is the all time high quarterly working capital for Akero Therapeutics?
Akero Therapeutics all-time high quarterly working capital is $881.02 M
What is Akero Therapeutics quarterly working capital year-on-year change?
Over the past year, AKRO quarterly working capital has changed by +$156.06 M (+28.50%)